Transcription of 2020 Form 10-K
{{id}} {{{paragraph}}}
UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, 20549. form 10-K. (Mark One). ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2020. or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from _____ to_____. Commission file number: 001-01011. CVS HEALTH CORPORATION. (Exact name of registrant as specified in its charter). Delaware 05-0494040. (State or other jurisdiction of incorporation or organization) ( Employer Identification No.)
Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations 66 Item 7A: Quantitative and Qualitative Disclosures About Market Risk 97 Item 8: Financial Statements and Supplementary Data 100 Item 9: Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 176
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}